Literature DB >> 22342295

Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency.

Vladimir K Bakalov1, Liat Gutin, Clara M Cheng, Jian Zhou, Puja Sheth, Kavita Shah, Sruthi Arepalli, Vien Vanderhoof, Lawrence M Nelson, Carolyn A Bondy.   

Abstract

The higher prevalence of autoimmune diseases in women compared to men could be due to effects of ovarian hormones, pregnancy and/or the presence of a second X chromosome. To elucidate the role of these factors, we investigated the prevalence and spectrum of autoimmune diagnoses in women with primary ovarian insufficiency associated with X chromosome monosomy (Turner syndrome, TS, n = 244) and women with karyotypically normal (46,XX) primary ovarian insufficiency (POI, n = 457) in a prospective study, conducted at the National Institutes of Health. We compared the study group prevalence to normative data for the U.S. population of women. Chronic lymphocytic (Hashimoto's) thyroiditis (HT) occurred in 37% of women with TS vs. 15% with POI (P < 0.0001); HT prevalence in both ovarian insufficiency groups significantly exceeded that in U.S. population of women (5.8%). Inflammatory bowel (IBD, 4%) and celiac disease (CD, 2.7%) were significantly increased in TS, but not in POI. No other autoimmune diagnosis, including Graves' disease or Type 1 diabetes appears to be significantly increased in either group. Women with TS had higher pro-inflammatory IL6 and TGF β1 levels (p < 0.0001 for both), and lower anti-inflammatory IL10 and TGF β2 levels (p < 0.005 for both) compared to POI and to normal volunteers. Lifetime estrogen exposure and parity were significantly lower in TS compared to POI, which were in turn lower than the general population of women. The finding that lymphocytic thyroiditis is greatly increased in both women with TS and POI suggests that factors associated with ovarian insufficiency per se promote this form of autoimmunity. The absence of a normal second X-chromosome further contributes to increased autoimmunity in TS. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342295      PMCID: PMC3358475          DOI: 10.1016/j.jaut.2012.01.015

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  49 in total

1.  Prevalence and clinical picture of celiac disease in Turner syndrome.

Authors:  Margherita Bonamico; Anna M Pasquino; Paolo Mariani; Helene M Danesi; Franco Culasso; Laura Mazzanti; Antonella Petri; Giovanni Bona
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

Review 2.  Blistering disorders: diagnosis and treatment.

Authors:  S W Yeh; Babar Ahmed; Naveed Sami; A Razzaque Ahmed
Journal:  Dermatol Ther       Date:  2003       Impact factor: 2.851

3.  Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects.

Authors:  W Gilmore; L P Weiner; J Correale
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

Review 4.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

5.  Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure.

Authors:  T J Kim; J N Anasti; M R Flack; L M Kimzey; R A Defensor; L M Nelson
Journal:  Obstet Gynecol       Date:  1997-05       Impact factor: 7.661

6.  Morbidity in Turner syndrome.

Authors:  C H Gravholt; S Juul; R W Naeraa; J Hansen
Journal:  J Clin Epidemiol       Date:  1998-02       Impact factor: 6.437

Review 7.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Authors:  D L Jacobson; S J Gange; N R Rose; N M Graham
Journal:  Clin Immunol Immunopathol       Date:  1997-09

8.  Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.

Authors:  C H Gravholt; B Svenstrup; P Bennett; J Sandahl Christiansen
Journal:  Clin Endocrinol (Oxf)       Date:  1999-06       Impact factor: 3.478

9.  Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey.

Authors:  Michael M Ward
Journal:  J Womens Health (Larchmt)       Date:  2004 Jul-Aug       Impact factor: 2.681

10.  Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001.

Authors:  Joseph A Murray; Carol Van Dyke; Matthew F Plevak; Ross A Dierkhising; Alan R Zinsmeister; L Joseph Melton
Journal:  Clin Gastroenterol Hepatol       Date:  2003-01       Impact factor: 11.382

View more
  37 in total

Review 1.  Cytokine gene considerations in giant cell arteritis: IL10 promoter polymorphisms and a review of the literature.

Authors:  Lorena Alvarez-Rodriguez; Marcos Lopez-Hoyos; Eugenio Carrasco-Marín; Gaurav Tripathi; Pedro Muñoz Cacho; Cristina Mata; Jaime Calvo-Alen; Maite Garcia-Unzueta; Elena Aurrecoechea; Victor Manuel Martinez-Taboada
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

2.  Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome.

Authors:  Allison J Pollock; Tasa S Seibert; Cristiana Salvatori; Patrizio Caturegli; David B Allen
Journal:  Horm Res Paediatr       Date:  2016-06-30       Impact factor: 2.852

3.  Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome.

Authors:  Lauren J Massingham; Kirby L Johnson; Thomas M Scholl; Donna K Slonim; Heather C Wick; Diana W Bianchi
Journal:  Hum Genet       Date:  2014-05-22       Impact factor: 4.132

Review 4.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

Review 5.  Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature.

Authors:  M Agopiantz; P Corbonnois; A Sorlin; C Bonnet; M Klein; N Hubert; V Pascal-Vigneron; P Jonveaux; T Cuny; B Leheup; G Weryha
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

6.  2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.

Authors:  Kris Poppe; Peter Bisschop; Laura Fugazzola; Gesthimani Minziori; David Unuane; Andrea Weghofer
Journal:  Eur Thyroid J       Date:  2021-01-21

Review 7.  Inflammatory Bowel Disease: Influence and Implications in Reproduction.

Authors:  Louise E Glover; Blair Fennimore; Mary Wingfield
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

Review 8.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

9.  21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I.

Authors:  A Berglund; L Cleemann; B E Oftedal; K Holm; E S Husebye; C H Gravholt
Journal:  Clin Exp Immunol       Date:  2018-11-14       Impact factor: 4.330

Review 10.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.